Savara, Inc. (SVRA)
4.72
-0.27
(-5.41%)
USD |
NASDAQ |
Nov 12, 16:00
4.79
+0.07
(+1.48%)
After-Hours: 20:00
Savara Price : 4.72 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 4.99 | 5.03 | 4.67 | 4.72 | 4.297M |
| Nov 11, 2026 | 4.99 | 5.205 | 4.91 | 4.99 | 9.263M |
| Nov 10, 2026 | 4.92 | 5.150 | 4.84 | 4.92 | 1.730M |
| Nov 09, 2026 | 4.943 | 5.065 | 4.76 | 5.05 | 2.404M |
| Nov 06, 2026 | 4.46 | 4.895 | 4.41 | 4.83 | 2.227M |
| Nov 05, 2026 | 4.63 | 4.636 | 4.325 | 4.38 | 2.900M |
| Nov 04, 2026 | 4.84 | 4.88 | 4.46 | 4.66 | 3.560M |
| Nov 03, 2026 | 4.78 | 4.88 | 4.655 | 4.75 | 2.111M |
| Nov 02, 2026 | 4.83 | 4.91 | 4.67 | 4.73 | 1.778M |
| Oct 30, 2026 | 4.88 | 4.97 | 4.750 | 4.82 | 1.412M |
| Oct 29, 2026 | 5.05 | 5.135 | 4.915 | 4.95 | 1.741M |
| Oct 28, 2026 | 4.82 | 5.05 | 4.775 | 5.02 | 1.787M |
| Oct 27, 2026 | 4.49 | 4.905 | 4.45 | 4.86 | 3.591M |
| Oct 26, 2026 | 4.335 | 4.54 | 4.216 | 4.52 | 3.449M |
| Oct 23, 2026 | 4.52 | 4.58 | 4.13 | 4.22 | 2.829M |
| Oct 22, 2026 | 4.65 | 4.75 | 4.45 | 4.54 | 2.710M |
| Oct 21, 2026 | 4.79 | 4.945 | 4.66 | 4.67 | 2.087M |
| Oct 20, 2026 | 4.64 | 4.99 | 4.60 | 4.76 | 4.422M |
| Oct 19, 2026 | 4.53 | 4.705 | 4.495 | 4.63 | 1.564M |
| Oct 16, 2026 | 4.75 | 4.77 | 4.44 | 4.45 | 2.237M |
| Oct 15, 2026 | 4.76 | 4.90 | 4.72 | 4.74 | 1.691M |
| Oct 14, 2026 | 4.71 | 4.82 | 4.65 | 4.76 | 2.574M |
| Oct 13, 2026 | 4.84 | 5.02 | 4.76 | 4.78 | 3.742M |
| Oct 12, 2026 | 4.93 | 5.00 | 4.81 | 4.84 | 1.307M |
| Oct 09, 2026 | 4.82 | 4.975 | 4.81 | 4.92 | 1.529M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.14 |
| Alnylam Pharmaceuticals, Inc. | 156.65 |
| Anika Therapeutics, Inc. | 13.81 |
| Vericel Corp. | 57.42 |
| Biogen, Inc. | 250.48 |
Price Related Metrics
| PEG Ratio | -0.5603 |
| Price to Book Value | 8.995 |
| Earnings Yield | -12.90% |
| Market Cap | 970.13M |
| PEGY Ratio | -0.5603 |